Urea compounds disclosed herein increase HDL-C levels and as such can be used in prevention and treatment of atherosclerosis, myocardial infarction and related conditions such as peripheral vascular disease and ischemic stroke hypoalphalipoproteinemia.

Hierin onthulde de samenstellingen van het ureum verhogen niveaus hdl-c en kunnen als dusdanig in preventie en behandeling van atherosclerose, myocardiaal infarct en verwante voorwaarden zoals rand vasculaire ziekte en ischemische slaghypoalphalipoproteinemia worden gebruikt.
 
Web www.patentalert.com

< Polyhydroxyalkanoate and method of producing same, and .omega.-(2-thienylsulfanyl) alkanoic acid and method of producing same

< Ligands for opioid receptors

> Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby

> Compounds specific to adenosine A1 receptors and uses thereof
~ 00098